Article

Epidural Steroid Safety Advice Focuses on Imaging

A multidisciplinary group has issued guidelines for lowering the risk of neurological injuries tied to injections for short-term relief of radicular pain.

Benzon HT, Huntoon MA, Rathmell JP. Improving the Safety of Epidural Steroid Injections.JAMA. 2015; doi:10.1001/jama.2015.2912. Online March 30, 2015.

New recommendations on epidural steroid injections seek to reduce or eliminate rare but catastrophic central nervous system injuries. Effective imaging guidance is crucial, they say.

A multidisciplinary team reviewed case reports and malpractice claims1 to develop guidelines for improving the safety of the millions of injections given to US patients. There were 2.3 million procedures among Medicare patients alone in 2011, the authors note.

Two noteworthy issues are the risks of particulate versus nonparticulate steroids, and the need for contrast medium in fluoroscopic guidance.

Injuries following nonparticulate injections are temporary, whereas paraplegias after particulate steroids are permanent, they point out.

Also, cervical injections require more caution than lumbar injections.

The recommendations include specific guidance about when to use contrast medium, what kind of imaging guidance to use for different locations of injections, and when to choose particulate as opposed to nonparticulate steroids.

Epidural steroid injections will continue to be used for short-term relief of radicular pain,” the authors state. They add that unanswered questions remain regarding the efficacy of nonparticulate steroids and whether using a lower dose would still produce a “meaningful reduction in pain.”

 

References:

1. Rathmell JP, Benzon HT, Dreyfuss P, et al. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology. 2015; doi:10.1097/ALN.0000000000000614. Online February 9, 2015.

 

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.